´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦31Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2022-05-20±³À°ÀÏÀÚ : 2022-05-20
±³À°Àå¼Ò : °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B ¿Ü 1°³·ë
±³À°ÁÖÁ¦ :
Á¦31Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ :
office@intervention.or.kr ±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï-Á¤È¸¿ø50000¿ø, Àü¹®ÀÇ100000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 30000¿ø, ÁØȸ¿ø¹×±âŸ 50000¿ø/ÇöÀåµî·Ï-Á¤È¸¿ø70000¿ø, Àü¹®ÀÇ120000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 50000¿ø, ÁØȸ¿ø¹×±âŸ 70000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:00~13:07 Factors for successful transvenous retrograde thoracic duct cannulation ±èÇüõ(°Ç¾çÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:07~13:10 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:10~13:17 To evaluate technical success and safety of a planned percutaneous transhepatic approach (PPTA) to the thoracic duct Á¤±¸¼º(õ¾ÈÃ湫º´¿ø)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:17~13:20 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:20~13:27 Efficacy and Safety of Large-Bore Uncovered Stents for Malignant Superior Vena Cava Syndrome ÃÖ»ó¸²(Áß¾Ó´ëÇб³ ±¤¸íº´¿ø)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:27~13:30 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:30~13:37 Deep learning quantification of degree of AVF stenosis and prediction of 6months primary patency based on AVF shunt sound ¹®¼º¸ð(¿¬¼¼ÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:37~13:40 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:40~13:47 The Usefulness of Catheter Length Prediction Formula Using Only the Anteroposterior Chest Radiograph and Wireless Ultrasound System in Bedside PICC Insertion: A Single Center Experience for Patients in COVID-19 Isolation Ward ¹Ú¼ºÁØ(°í·ÁÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:47~13:50 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:50~13:57 Effectiveness of two sessions of catheter-directed sclerotherapy for ovarian endometrioma ½ÅÁöÈÆ(¿ï»êÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:57~14:00 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:00~14:15 Vessel preparation: when and how ±ÇÁØÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:15~14:30 Drug coated balloons: are there any differences? ±è¹Î¿í(º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:30~14:45 Stents: what are the remaining roles of stents in SFA in an era of drug technology Á¶¼ö¹ü(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:45~15:00 BTK angioplasty for limb salvage: how I do it ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:00~15:15 Is DVA a viable option for "no option" limb or "desert foot" ±Ç¿äÇÑ(¾ÆÁÖÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:15~15:20 Discussion ()
ÈÞ½Ä 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:20~15:40 Coffee break ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:40~15:55 Clinical evaluation of varicose vein patients Á¶ÁøÇö(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:55~16:10 Radiological evaluation of varicose vein patients ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:10~16:25 Update in varicose vein intervention ÀÌÀ±ÇÐ(¼¿ï¼±Ç÷°üÅëÁõ¼¾ÅÍ)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:25~16:45 Various devices for endovenous procedure for varicose vein (case based) ȲÁøÈ£(°Ç±¹ÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:45~16:50 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:50~17:20 What¡¯s new ½ÉÀçÇö, ÀÌ¿ì¶÷(Boston, COOK)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:00~13:07 Catheter-directed sclerotherapy versus Surgical excision with subsequent Dienogest therapy for the treatment of ovarian endometrioma: Propensity score analyses of short-term outcomes ÀÌÀçȯ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:07~13:10 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:10~13:17 Modified surgical drain-guided percutaneous catheter drainage for postoperative fluid collection in inaccessible locations ÀÌÇü³²(¼øõÇâÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:17~13:20 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:20~13:27 Pathologic response of single hepatocellular carcinoma treated with balloon-occluded transcatheter arterial chemoembolization ±èÁöÈÆ(¿ï»êÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:27~13:30 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:30~13:37 Percutaneous nephrostomy for complex renal stone : Percutaneous renal access behind a stone ¾ÈÀç°æ(°æ»óÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:37~13:40 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:40~13:47 Comparison of technical feasibility and clinical outcomes between 6Fr and 8Fr Double J Stents for Ureteral Obstruction ¿ÀâÈÆ(°í·ÁÀÇ´ë)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:47~13:50 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 13:50~13:57 Outcomes of percutaneous transhepatic treatment for bile duct stones a multicenter retrospective study in 2431 patients Á¤±Ô½Ä(¿ï»êº´¿ø)
Åä·Ð 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:57~14:00 Discussion ()
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 14:00~14:20 Hemodynamics of HCC Á¤Áø¿í(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 14:20~14:40 Drug preparation - lipiodol and embolic materials ±èȿö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 14:40~15:00 Superive TACE ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 15:00~15:20 Arterial anatomy - What to know during TACE ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 05-20 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 205+206 15:20~15:40 Coffee break ()